Vieira Dayse, Eikelboom Robert, Ivey Gemma, Miller Stuart
The University of Western Australia, Nedlands, Australia.
Int Tinnitus J. 2011;16(2):111-7.
The Neuromonics Tinnitus Treatment is based on individually customized acoustic stimulation and structured counseling.
To assess the long-term clinical outcomes of the Neuromonics Tinnitus Treatment, specifically, to determine whether benefits achieved at the conclusion of the prescribed treatment program were retained over the longer term.
This study involved 70 subjects who had previously undergone the treatment across six clinics located in Australia and United States. Patients had concluded the treatment at least six, and up to 36 months, before the commencement of this study. The Tinnitus Reaction Questionnaire was used to assess tinnitus distress, and patients were asked to report on percentage of time of awareness of and disturbance by their tinnitus. Long-term data were compared to data reported throughout the course of the treatment.
Patients achieved statistically significant improvement of their tinnitus distress. The success rate (at least 40% reduction in TRQ score) for this cohort of patients was 75.7% at the conclusion of the program and the majority of patients sustained the benefits in the long-term. Results revealed that NTT provides a consistent and stable relief of tinnitus distress.
Neuromonics耳鸣治疗法基于个性化定制的声学刺激和结构化咨询。
评估Neuromonics耳鸣治疗法的长期临床效果,具体而言,确定在规定治疗方案结束时所取得的益处是否能在更长时间内得以保持。
本研究涉及70名曾在位于澳大利亚和美国的六家诊所接受过该治疗的受试者。在本研究开始前,患者已结束治疗至少6个月,最长达36个月。使用耳鸣反应问卷评估耳鸣困扰程度,并要求患者报告其耳鸣被感知和造成困扰的时间百分比。将长期数据与整个治疗过程中报告的数据进行比较。
患者的耳鸣困扰程度在统计学上有显著改善。该组患者在治疗方案结束时的成功率(耳鸣反应问卷得分至少降低40%)为75.7%,且大多数患者在长期内维持了这些益处。结果表明,Neuromonics耳鸣治疗法能持续稳定地缓解耳鸣困扰。